# Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)

> **NCT00442338** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 91 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** montelukast sodium
- **DRUG:** montelukast sodium
- **DRUG:** aminophylline hydrate

## Key facts

- **NCT ID:** NCT00442338
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2022-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00442338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00442338, "Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00442338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*